FORZ (Forza Innovations) EV-to-EBIT: 0.00 (As of Jul. 07, 2026)


What is Forza Innovations EV-to-EBIT?

Forza Innovations FORZ -99.00% EV-to-EBIT is 0.00 as of Jul. 07, 2026.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Forza Innovations's Enterprise Value is $0.00 Mil. Forza Innovations's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.32 Mil. Therefore, Forza Innovations's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Forza Innovations's EV-to-EBIT or its related term are showing as below:

FORZ's EV-to-EBIT is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 18.635
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Forza Innovations's Enterprise Value for the quarter that ended in Dec. 2023 was $2.63 Mil. Forza Innovations's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.32 Mil. Forza Innovations's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -50.11%.

Forza Innovations  (OTCPK:FORZ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Forza Innovations's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-1.316/2.6261653
=-50.11 %

Forza Innovations's Enterprise Value for the quarter that ended in Dec. 2023 was $2.63 Mil.
Forza Innovations's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Forza Innovations EV-to-EBIT Related Terms

Forza Innovations EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Forza Innovations's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Forza Innovations EV-to-EBIT Chart

Forza Innovations Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-EBIT
Get a 7-Day Free Trial 0.00 -15.68 -71.91 -1.17 -0.67

Forza Innovations Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.80 -0.81 -0.67 -0.78 -2.00

FORZ vs USAQ, EMED, RTSL: EV-to-EBIT Comparison

For the Medical Devices subindustry, Forza Innovations's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Forza Innovations EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Forza Innovations's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Forza Innovations's EV-to-EBIT falls into.


Forza Innovations EV-to-EBIT Calculation

Forza Innovations's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/-1.316
=0.00

Forza Innovations's current Enterprise Value is $0.00 Mil.
Forza Innovations's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of 0.00 mean?
Forza Innovations (FORZ) has a EV-to-EBIT of 0.00 as of Jul. 07, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Forza Innovations and its competitors.
Is Forza Innovations' EV-to-EBIT too high?
Forza Innovations' current EV-to-EBIT is 0.00.
How does Forza Innovations' EV-to-EBIT compare to USAQ and EMED?
Forza Innovations' EV-to-EBIT of 0.00 can be compared against companies in the Medical Devices & Instruments industry. The industry median EV-to-EBIT is 18.64. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.64, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Forza Innovations and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Forza Innovations's current EV-to-EBIT is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forza Innovations stock overvalued right now?
Forza Innovations (FORZ) has a current EV-to-EBIT of 0.00. The current EV-to-EBIT is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Forza Innovations (FORZ), the current EV-to-EBIT is 0.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Forza Innovations Business Description

Address 406 9th Avenue, Suite 210, San Diego, CA, USA, 92101
Forza Innovations Inc is in the health-tech wearable performance business. The company has acquired all the ownership and rights to certain late developmental-stage products, including the J4 Sport, J4 X, and J4 Fitbelt. These products are wearable back compression devices, used to relax, warm up, loosen, or relax stiff & sore muscles. The therapeutic application of heat causes a change in the temperature of the soft tissues which decreases joint stiffness and relieves inflammation.